Riskpilot← Back to searchSign inGet full accessWS Audiology Sweden AB
ABActiveOrg 5560869769Höjdrodergatan 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19635 employees
Revenue 2025
SEK 6,6M
-77% vs 2024
EBITDA margin
8.2%
-60% vs 2024
Equity ratio
89.0%
Financial strength
Net profit 2025
SEK 484K
-73% vs 2024
| Revenue | SEK 6,6M | -77% |
| EBITDA | SEK 540K | -60% |
| Net profit | SEK 484K | -73% |
| Total assets | SEK 22,1M | +5% |
| Equity | SEK 19,6M | +3% |
| Employees | 5 | — |
Legal name
WS Audiology Sweden AB
Org number
5560869769
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22 mars 1963
Share capital
SEK 900 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utveckling, tillverkning, försäljning, installation av och utöva serviceverksamhet för hörseltekniska hjälpmedel, hälso- och sjukvård samt annan därmed förenlig verksamhet, ävensom äga och förvalta fastigheter, aktier och andra värdehandlingar.
Address
Höjdrodergatan 4
Phone
+46406801400
Email
info@widex.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 27 980 | 34 210 | 35 300 | 28 470 | 6 582 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 056 | 1 120 | 1 794 | 1 356 | 540 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 056 | 1 120 | 1 794 | 1 356 | 540 |
| Net financials | −436 | −687 | 232 | 543 | 198 |
| Profit before tax | 620 | 433 | 2 027 | 1 898 | 834 |
| Tax | −68 | −700 | −192 | −106 | −350 |
| Net profit | 552 | −267 | 1 835 | 1 792 | 484 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 29 978 | 20 279 | 22 193 | 21 075 | 22 065 |
| Equity | 15 922 | 15 528 | 17 363 | 19 156 | 19 640 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 666 | 4 323 | 4 349 | 1 918 | 2 425 |
| Total debt | 12 666 | 4 323 | 4 349 | 1 918 | 2 425 |
EBITDA margin
8.2%
This company
15.8%
Market median
-48% vs market
20212025
Equity ratio
89.0%
This company
38.2%
Market median
+133% vs market
20212025
Return on equity
2.5%
This company
18.4%
Market median
-86% vs market
20212025
Net profit margin
7.4%
This company
8.1%
Market median
-9% vs market
20212025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TK Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
PJ Chief Auditor | Chief Auditor | 2025 |
MR Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (5) | ||
MD Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
EM Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2022 |
JR Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
AV Chief Auditor | Chief Auditor | 2021 – 2025 |
HS Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 | |
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
WS AUDIOLOGY A/S
WS Audiology Sweden AB (this company)Board members of WS Audiology Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Damm Jensen | Chief Executive Officer | 0 companies |
| Eva Maria Lilja | Authorized Recipient of Service | 0 companies |
| Jan-Peter Rekling | Chief Executive Officer | 0 companies |
| Andreas Vallentin | Chief Auditor | 0 companies |
| Totte Kristofer Nils F Axelsson | Authorized Recipient of Service | 0 companies |
| Patrik John Martin Larsson | Chief Auditor | 0 companies |
| Michelle Reyneke | Chief Executive Officer | 0 companies |
| Henrik Skak Bender | Chief Executive Officer | 0 companies |
| Vivian Herforth Sommer | Deputy Board Member | 0 companies |
| Annemarie Johanna van Neck | Board of Directors | 0 companies |
| Carsten Buhl | Board of Directors | 0 companies |
| Jack Kenneth Sørensen | Deputy Board Member | 0 companies |
| Christian Sokcevic | Deputy Board Member | 0 companies |